Amplia Therapeutics Ltd.ASX: ATX

Second Complete Response in ACCENT Pancreatic Cancer Trial

Jun 19, 2025 at 2:53 AM UTC · Issued by Amplia Therapeutics Ltd.

Amplia Therapeutics Ltd has released a press release.

View Attachment